Need Help?

Multi-omics of Richter syndrome

Richter syndrome (RS) is the aggressive transformation of Chronic Lymphocytic Leukemia, mostly with Diffuse Large B-Cell Lymphoma histology. While histologically similar, RS and de novo DLBCLs present with different clinical courses. We characterized the RS epigenome by combining genome-wide DNA methylation with transcriptome-sequencing on a large RS cohort.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001007922 Illumina HiSeq 4000 77
EGAD00001009509 Illumina MiSeq 58
EGAD00010002194 Illumina EPIC microarray 90
Publications Citations
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
Blood Cancer Discov 4: 2023 150-169
7
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Nat Med 29: 2023 158-169
21
Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
Nat Commun 14: 2023 309
10
ZNF683 marks a CD8<sup>+</sup> T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Cancer Cell 41: 2023 1803-1816.e8
9